← Health care and life sciences companies

    ADARx Pharmaceuticals: company profile, size and contacts

    adarx.comActiveFor profit

    ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

    Employees
    11-50
    Founded
    2019
    Total raised
    $332M
    Region
    Greater San Diego Area

    Company facts

    Website
    adarx.com
    Location
    Greater San Diego Area, West Coast, Western US
    Employees
    11-50
    Founded
    2019 (7 years ago)
    Categories
    Biotechnology, Health Care, Medical, Pharmaceutical
    Company type
    For profit
    Listing
    Private
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founder

    • Zhen LiFounder · ADARx Pharmaceuticals

    ADARx Pharmaceuticals was founded in 2019 by Zhen Li.

    Funding

    Total raised
    $332M
    Funding rounds
    5
    Latest round
    Series C, 2023-08
    Investors
    17
    Lead investors
    5

    How ADARx Pharmaceuticals compares

    • Size: ADARx Pharmaceuticals has more employees than 15% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: ADARx Pharmaceuticals is older than 5% of the 1166 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 28 based in Greater San Diego Area.

    Growth outlook

    • Trend: Growing
    • Direction: Growing
    • Confidence: High

    ADARx Pharmaceuticals may be growing as it has successfully secured a significant amount of funding, with $200 million raised in an oversubscribed Series C financing round. This influx of capital is intended to advance the company's clinical programs, which includes the development of ADX-324, a treatment in their pipeline. The ability to raise funds beyond the initial target suggests strong investor confidence in the company's potential and its ongoing projects.

    What ADARx Pharmaceuticals says about itself

    “Amplifying Science Leveraging our decades of siRNA drug development experience and proprietary technologies, we are focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Learn more about our next-generation research technologies.” adarx.com

    ADARx Pharmaceuticals in short

    ADARx Pharmaceuticals has a 11-50 person team and operates in biotechnology, listed under Greater San Diego Area, and has been around since 2019. Its founder is Zhen Li and it has raised $332 million over 5 rounds.

    Frequently asked questions

    What does ADARx Pharmaceuticals do?
    ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
    When was ADARx Pharmaceuticals founded?
    ADARx Pharmaceuticals was founded in 2019, so it is about 7 years old.
    How many employees does ADARx Pharmaceuticals have?
    Crunchbase lists ADARx Pharmaceuticals in the 11-50 employee range.
    Where is ADARx Pharmaceuticals based?
    ADARx Pharmaceuticals is listed under Greater San Diego Area, West Coast, Western US.
    Has ADARx Pharmaceuticals raised funding?
    Crunchbase records $332M raised across 5 funding rounds, most recently series c in 2023-08.
    How do I find email addresses at ADARx Pharmaceuticals?
    Search the domain adarx.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.